Not applicableStudy completedNCT03455387
What this trial is testing
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
Who this might be right for
Pre-EclampsiaHELLP SyndromeFetal Death+3 more
Centre Hospitalier Metropole Savoie 233